Atlas Trials

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN

Clinical trial NCT02630277 · UNKNOWN

Trial details

NCT number
NCT02630277
Sponsor
Valley Retina Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2016-01-01
Primary completion
2017-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.